ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION

Published:2019-03 Issue:3 Volume:39 Page:426-434
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Bonnin Sophie,Dupas Bénédicte,Lavia Carlo,Erginay Ali,Dhundass Myriam,Couturier Aude,Gaudric Alain,Tadayoni Ramin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference27 articles.

1. Change in diabetic retinopathy through 2 years: secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab;Bressler;JAMA Ophthalmol,2017

2. Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography;Silva;Ophthalmology,2015

3. Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab;Bressler;Ophthalmology,2017

4. Clinical examination accurately locates capillary nonperfusion in diabetic retinopathy;Kimble;Am J Ophthalmol,2005

5. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales;Wilkinson;Ophthalmology,2003

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of brolucizumab on diabetic macular edema and ischemia; a real world analysis;2024-08-16

2. Central retinal vein occlusion in patients with metastatic solid tumors on tyrosine kinase inhibitors: a report of case series and literature review;Frontiers in Medicine;2024-06-20

3. Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System;Ophthalmology Science;2024-05

4. Peripheral retinal lesions in diabetic retinopathy on ultra-widefield imaging;Saudi Journal of Ophthalmology;2024-01-06

5. Diabetic retinopathy: New insights;Chronic Complications of Diabetes Mellitus;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3